未登录

M

Mathilde Poussin

perelman school of medicineat the university of pennsylvania

H指数:26

被引数:3,670

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy

靶向突变型KRAS肽的CAR-T细胞工程化构建用于癌症治疗

IF44.5

2025-06-050

PRE

In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB) (vol 71, pg 4617, 2011)

CANCER RESEARCH

IF16.6

2024-02-150

OA

TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones

IF7.1

2023-04-285

OAAI

Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-07-1217

OAAI

CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy

NATURE COMMUNICATIONS

IF15.7

2021-02-09201

OAAI

Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2020-03-1956

OAAI

CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies

MOLECULAR THERAPY

IF12

2020-02-0129

OAAI

Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy

MOLECULAR THERAPY

IF12

2016-11-0155

OAAI

Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2016-07-20110

OAAI

High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity

IF13.4

2016-02-22109

OAAI

Exploring On-Target Hematopoietic Toxicity With Highly Potent, High Affinity FRβ-Specific CAR T Cells for AML

MOLECULAR THERAPY

IF12

2015-05-010

OAAI

Targeting the Negative Immune Regulatory Molecule B7-H4 on Both Tumor and Normal Tissue With Anti-B7-H4 CAR T Cells

MOLECULAR THERAPY

IF12

2015-05-010

OAAI

A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor

CANCER RESEARCH

IF16.6

2012-04-01308

OAAI

Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor

MOLECULAR THERAPY

IF12

2012-03-01194

OAAI

In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)

CANCER RESEARCH

IF16.6

2011-06-30310

OAAI

Evidence for the involvement of ActA in maturation of the Listeria monocytogenes phagosome

IF25.9

2009-12-2214

OAAI

The ability of Listeria monocytogenes PI-PLC to facilitate escape from the macrophage phagosome is dependent on host PKCβ

MICROBIAL PATHOGENESIS

IF3.5

2009-01-0137

OAAI

Evidence for glycosylphosphatidylinositol (GPI)-anchored eosinophil-derived neurotoxin (EDN) on human granulocytes

IF3

2003-02-075

PREAI